Detalhe da pesquisa
1.
Factors influencing the indication of coronary angiography in patients presenting with chest pain unspecified: an analysis of two decades (1994-2014).
Int J Qual Health Care
; 36(1)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408270
2.
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
Circulation
; 141(9): 728-739, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707860
3.
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
N Engl J Med
; 375(6): 534-44, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27232649
4.
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
N Engl J Med
; 375(12): 1131-41, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573206
5.
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
Circulation
; 135(7): 648-655, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881569
6.
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
N Engl J Med
; 373(25): 2413-24, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559317
7.
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Am Heart J
; 185: 93-100, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267480
8.
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.
J Thromb Thrombolysis
; 44(4): 457-465, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905172
9.
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
Pharm Stat
; 16(6): 445-450, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28840662
10.
Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification.
Front Pharmacol
; 15: 1325186, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384289
11.
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Clin Kidney J
; 15(1): 136-144, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35035944
12.
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.
Clin Kidney J
; 14(1): 366-374, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564440
13.
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
Clin J Am Soc Nephrol
; 16(5): 736-745, 2021 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835939
14.
Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment.
Am Heart J
; 169(1): 186-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25497265
15.
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Am J Cardiovasc Drugs
; 10(3): 175-86, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20524719
16.
Left Pericardiophrenic Vein Pacing for Tachy-Brady Syndrome Due to an Obstructing Cardiac Angiosarcoma.
JACC Case Rep
; 2(11): 1771-1775, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34317054
17.
A novel assay to measure calcification propensity: from laboratory to humans.
Sci Rep
; 10(1): 17578, 2020 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067536
18.
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.
Kidney Int Rep
; 5(12): 2178-2182, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305110
19.
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.
Br J Pharmacol
; 177(19): 4400-4415, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557649
20.
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
J Nephrol
; 32(5): 811-821, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401795